About
Cardiac Dimensions is a medical technology company based in Kirkland, Washington, with additional operations in Sydney, Australia, and Frankfurt, Germany. Founded in 2001, the company employs around 65 people, with a significant portion based in Europe. It specializes in developing minimally invasive therapies for heart failure, particularly focusing on mitral valve regurgitation. The company's flagship product is the Carillon Mitral Contour System, designed to address leaky mitral valves through a minimally invasive procedure. This system aims to enhance heart function and improve patient outcomes without the need for open-heart surgery. The Carillon system has received CE Mark approval and is available in Europe and other regions that recognize European medical device standards. In the U.S. and Canada, it is currently investigational and used in clinical trials. Cardiac Dimensions has conducted several clinical trials to assess the safety and efficacy of the Carillon system and is actively enrolling patients in ongoing studies. The company has raised over $200 million in funding to support its research and global expansion efforts.
Technologies
Keywords
Company Information
-
Employees 59
-
Founded 2001
-
Annual Revenue $11000000
-
Total Funding $168200000
Location
5540 Lake Washington Boulevard Northeast, Kirkland, Washington, United States, 98033
